Lipid-specific binding of the calcium-dependent antibiotic daptomycin leads to changes in lipid polymorphism of model membranes

Chemistry and Physics of Lipids

Volumn 154, Issue 2, 2008, Pages 120-128

  Jung, David ^a   Powers, Jon Paul ^a   Straus, Suzana K ^a   Hancock, Robert E W ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

31P NMR; Daptomycin; DSC; Fluorescence; Lipopeptide; Membrane fusion; Model membranes

Indexed keywords

CALCIUM; DAPTOMYCIN; KYNURENINE; LIPID;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; ELECTRICITY; HYDROPHOBICITY; MEMBRANE BINDING; MEMBRANE MODEL; PRIORITY JOURNAL; SPECTROSCOPY;

CALCIUM; CALORIMETRY, DIFFERENTIAL SCANNING; DAPTOMYCIN; DIMYRISTOYLPHOSPHATIDYLCHOLINE; FLUORESCENCE RESONANCE ENERGY TRANSFER; LIPOSOMES; MEMBRANE FUSION; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PHOSPHATIDYLGLYCEROLS;

EID: 46449102872     PISSN: 00093084     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chemphyslip.2008.04.004     Document Type: Article

References (41)

1. Ball L.J., Goult C.M., Donarski J.A., Micklefield J., and Ramesh V. NMR structure determination and calcium binding effects of lipopeptide antibiotic daptomycin. Org. Biomol. Chem. 2 (2004) 1872-1878
2. Boeck L.D., Papiska H.R., Wetzel R.W., Mynderse J.S., Fukuda D.S., Mertz F.P., and Berry D.M. A54145, a new lipopeptide antibiotic complex: discovery, taxonomy, fermentation and HPLC. J. Antibiot. (Tokyo) 43 (1990) 587-593
3. 31P NMR studies of unsonicated aqueous dispersions of neutral and acidic phospholipids. Effects of phase transitions, p2H and divalent cations on the motion in the phosphate region of the polar headgroup. Biochim. Biophys. Acta 436 (1976) 523-540
4. Cullis P.R., and de Kruijff B. Lipid polymorphism and the functional roles of lipids in biological membranes. Biochim. Biophys. Acta 559 (1979) 399-420
5. 31P NMR. Biochim. Biophys. Acta 552 (1979) 546-551
6. Debono M., Abbott B.J., Molloy R.M., Fukuda D.S., Hunt A.H., Daupert V.M., Counter F.T., Ott J.L., Carrell C.B., Howard L.C., et al. Enzymatic and chemical modifications of lipopeptide antibiotic A21978C: the synthesis and evaluation of daptomycin (LY146032). J. Antibiot. (Tokyo) 41 (1988) 1093-1105
7. Eliopoulos G.M., Willey S., Reiszner E., Spitzer P.G., Caputo G., and Moellering Jr. R.C. In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibiotic. Antimicrob. Agents Chemother. 30 (1986) 532-535
8. Ellens H., Bentz J., and Szoka F.C. Fusion of phosphatidylethanolamine-containing liposomes and mechanism of the L alpha-HII phase transition. Biochemistry 25 (1986) 4141-4147
9. Epand R.M., and Surewicz W.K. Effect of phase transitions on the interaction of peptides and proteins with phospholipids. Can. J. Biochem. Cell. Biol. 62 (1984) 1167-1173
10. Fass R.J., and Helsel V.L. In vitro activity of LY146032 against staphylococci, streptococci, and enterococci. Antimicrob. Agents Chemother. 30 (1986) 781-784
11. Foht P.J., Tran Q.M., Lewis R.N., and McElhaney R.N. Quantitation of the phase preferences of the major lipids of the Acholeplasma laidlawii B membrane. Biochemistry 34 (1995) 13811-13817
12. 2+-induced isotropic motion and phosphatidylcholine flip-flop in phosphatidylcholine-cardiolipin bilayers. Biochim. Biophys. Acta 598 (1980) 554-560
13. Gerritsen W.J., Henricks P.A., de Kruijff B., and van Deenen L.L. The transbilayer movement of phosphatidylcholine in vesicles reconstituted with intrinsic proteins from the human erythrocyte membrane. Biochim. Biophys. Acta 600 (1980) 607-619
14. Grunewald J., Kopp F., Mahlert C., Linne U., Sieber S.A., and Marahiel M.A. Fluorescence resonance energy transfer as a probe of peptide cyclization catalyzed by nonribosomal thioesterase domains. Chem. Biol. 12 (2005) 873-881
15. Hayami M., Okabe A., Kariyama R., Abe M., and Kanemasa Y. Lipid composition of Staphylococcus aureus and its derived L-forms. Microbiol. Immunol. 23 (1979) 435-442
16. Heimburg T., and Biltonen R.L. Thermotropic behavior of dimyristoylphosphatidylglycerol and its interaction with cytochrome c. Biochemistry 33 (1994) 9477-9488
17. Henzler-Wildman K.A., Martinez G.V., Brown M.F., and Ramamoorthy A. Perturbation of the hydrophobic core of lipid bilayers by the human antimicrobial peptide LL-37. Biochemistry 43 (2004) 8459-8469
18. Hojati Z., Milne C., Harvey B., Gordon L., Borg M., Flett F., Wilkinson B., Sidebottom P.J., Rudd B.A., Hayes M.A., Smith C.P., and Micklefield J. Structure, biosynthetic origin, and engineered biosynthesis of calcium-dependent antibiotics from Streptomyces coelicolor. Chem. Biol. 9 (2002) 1175-1187
19. Jones R.N., and Barry A.L. Antimicrobial activity and spectrum of LY146032, a lipopeptide antibiotic, including susceptibility testing recommendations. Antimicrob. Agents Chemother. 31 (1987) 625-629
20. Jung D., Rozek A., Okon M., and Hancock R.E.W. Structural transitions as determinants of the action of the calcium-dependent antibiotic daptomycin. Chem. Biol. 11 (2004) 949-957
21. Kirkpatrick P., Raja A., LaBonte J., and Lebbos J. Daptomycin. Nat. Rev. Drug. Discov. 2 (2003) 943-944
22. Kropacheva T.N., Salnikov E.S., Nguyen H.H., Reissmann S., Yakimenko Z.A., Tagaev A.A., Ovchinnikova T.V., and Raap J. Membrane association and activity of 15/16-membered peptide antibiotics: zervamicin IIB, ampullosporin A and antiamoebin I. Biochim. Biophys. Acta 1715 (2005) 6-18
23. Lakey J.H., and Ptak M. Fluorescence indicates a calcium-dependent interaction between the lipopeptide antibiotic LY146032 and phospholipid membranes. Biochemistry 27 (1988) 4639-4645
24. Liu L.P., and Deber C.M. Anionic phospholipids modulate peptide insertion into membranes. Biochemistry 36 (1997) 5476-5482
25. Lohner K., and Prenner E.J. Differential scanning calorimetry and X-ray diffraction studies of the specificity of the interaction of antimicrobial peptides with membrane-mimetic systems. Biochim. Biophys. Acta 1462 (1999) 141-156
26. Lohner K., Latal A., Lehrer R.I., and Ganz T. Differential scanning microcalorimetry indicates that human defensin, HNP-2, interacts specifically with biomembrane mimetic systems. Biochemistry 36 (1997) 1525-1531
27. 31P nuclear magnetic resonance and Fourier transform infrared spectroscopic, and X-ray diffraction studies. Biochemistry 38 (1999) 16514-16528
28. Mani R., Buffy J.J., Waring A.J., Lehrer R.I., and Hong M. Solid-state NMR investigation of the selective disruption of lipid membranes by protegrin-1. Biochemistry 43 (2004) 13839-13848
29. Muangsiri W., and Kirsch L.E. The kinetics of the alkaline degradation of daptomycin. J. Pharm. Sci. 90 (2001) 1066-1075
30. Prenner E.J., Lewis R.N., Neuman K.C., Gruner S.M., Kondejewski L.H., Hodges R.S., and McElhaney R.N. Nonlamellar phases induced by the interaction of gramicidin S with lipid bilayers A possible relationship to membrane-disrupting activity. Biochemistry 36 (1997) 7906-7916
31. Richard J.A., Kelly I., Marion D., Pezolet M., and Auger M. Interaction between beta-Purothionin and dimyristoylphosphatidylglycerol: a (31)P-NMR and infrared spectroscopic study. Biophys. J. 83 (2002) 2074-2083
32. Riske K.A., Fernandez R.M., Nascimento O.R., Bales B.L., and Lamy-Freund M.T. DMPG gel-fluid thermal transition monitored by a phospholipid spin labeled at the acyl chain end. Chem. Phys. Lipids 124 (2003) 69-80
33. Rotondi K.S., and Gierasch L.M. A well-defined amphipathic conformation for the calcium-free cyclic lipopeptide antibiotic, daptomycin, in aqueous solution. Biopolymers 80 (2005) 374-385
34. Scott W.R.P., Baek S.-B., Jung D., Hancock R.E.W., and Straus S.K. NMR structural studies of the antibiotic lipopeptide daptomycin in DHPC micelles. Biochim. Biophys. Acta 1768 (2008) 3116-3126
35. Silverman J.A., Perlmutter N.G., and Shapiro H.M. Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus. Antimicrob. Agents Chemother. 47 (2003) 2538-2544
36. Straus S.K., and Hancock R.E. Mode of action of the new antibiotic for Gram-positive pathogens daptomycin: comparison with cationic antimicrobial peptides and lipopeptides. Biochim. Biophys. Acta 1758 (2006) 1215-1223
37. Struck D.K., Hoekstra D., and Pagano R.E. Use of resonance energy transfer to monitor membrane fusion. Biochemistry 20 (1981) 4093-4099
38. Tally F.P., and DeBruin M.F. Development of daptomycin for gram-positive infections. J. Antimicrob. Chemother. 46 (2000) 523-526
39. Tally F.P., Zeckel M., Wasilewski M.M., Carini C., Berman C.L., Drusano G.L., and Oleson Jr. F.B. Daptomycin: a novel agent for Gram-positive infections. Expert Opin. Invest. Drugs 8 (1999) 1223-1238
40. Thennarasu S., Lee D.K., Tan A., Prasad Kari U., and Ramamoorthy A. Antimicrobial activity and membrane selective interactions of a synthetic lipopeptide MSI-843. Biochim. Biophys. Acta 1711 (2005) 49-58
41. Weinryb I., and Steiner R.F. Excited States of Proteins and Nucleic Acids (1971), Macmillan, London